Skip to main content
. 2021 Sep 15;13(9):10712–10720.

Table 1.

Clinical data of the patients (n [%]) (x ± sd)

Grouping Observation group (n = 23) Control group (n = 21) t/χ2 P
Gender 0.302 0.582
    Male 15 (65.22) 12 (57.14)
    Female 8 (34.78) 9 (42.86)
Age (years) 59.58±7.63 56.27±5.23 1.622 0.104
History of smoking 0.954 0.329
    Yes 11 (47.83) 7 (33.33)
    No 12 (52.17) 14 (66.67)
History of drinking consumption 0.302 0.583
    Yes 15 (65.22) 12 (57.14)
    No 8 (34.78) 9 (42.86)
Education level 2.277 0.131
    High school and below 9 (39.13) 13 (61.9)
    College and university 14 (60.87) 8 (38.1)
Residence 1.386 0.239
    Rural 15 (65.22) 10 (47.62)
    Urban 8 (34.78) 11 (52.38)
TNM Staging 0.192 0.661
    I + II 13 (56.52) 11 (52.38)
    III + IV 10 (43.48) 10 (47.62)
Pathological typing 0.341 0.560
    Diffuse 21 (91.3) 18 (85.71)
    Limited 2 (8.7) 3 (14.29)
Body mass index (kg/m2) 22.09±3.46 21.37±3.14 0.72 0.475
AST (U/L) 19.27±5.32 18.79±4.03 0.335 0.739
ALT (U/L) 21.58±6.31 22.19±6.75 1.601 0.117